- Condition: Coronary Artery Disease
Interventions: Device: PROMUS Element Plus Coronary Stent System; Drug: Aspirin; Drug: P2Y12 antagonist
Sponsors: Boston Scientific Corporation; Boston Scientific Corporation
Not yet recruiting - verified May 2012 - Conditions: Percutaneous Coronary Intervention; Dual Antiplatelet Therapy; Aspirin; Clopidogrel
Intervention:
Sponsors: Mount Sinai School of Medicine; Mount Sinai School of Medicine; Daiichi Sankyo Inc.; Accumetrics, Inc.
Recruiting - verified April 2012 - Conditions: Ischemic Stroke; Transient Ischemic Attack
Intervention: Dietary Supplement: omega-3 polyunsaturated fatty acids (Lovaza)
Sponsors: Millard Fillmore Gates Hospital; Millard Fillmore Gates Hospital; Kaleida Health
Recruiting - verified February 2012 - Condition: Stable Coronary Artery Disease
Interventions: Drug: Ticagrelor; Drug: Clopidogrel
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified April 2012 - Condition: Stable Coronary Artery Disease
Interventions: Drug: Ticagrelor; Drug: Clopidogrel
Sponsors: AstraZeneca; AstraZeneca
Recruiting - verified March 2012 - Conditions: Stroke; Transient Ischemic Attack; Myocardial Infarction
Intervention: Other: Pharmacogenomics testing for clopidogrel responsiveness
Sponsors: University of North Carolina, Chapel Hill; University of North Carolina, Chapel Hill; Kerr Drug; Laboratory Corporation of America
Recruiting - verified December 2011 - Condition: Healthy
Interventions: Drug: Rosuvastatin; Drug: Clopidogrel
Sponsors: University of California, San Francisco; University of California, San Francisco
Recruiting - verified April 2012 - Conditions: Cardiovascular Diseases; Acute Coronary Syndrome
Interventions: Drug: clopidogrel; Drug: prasugrel
Sponsors: University of Maryland; University of Maryland; National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified February 2012 - Condition: Stroke
Interventions: Drug: Anti-platelets and statin; Drug: alteplase; Procedure: intra arterial intervention
Sponsors: Jacobs Neurological Institute; Jacobs Neurological Institute; University at Buffalo Neurosurgery; Genentech
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Intervention: Other: Genotyping and platelet reactivity testing with the VerifyNow P2Y12 assay
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified March 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Prasugrel; Drug: Prasugrel
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified February 2012 - Condition: Acute Myocardial Infarction
Intervention:
Sponsors: Medstar Research Institute; Medstar Research Institute
Recruiting - verified April 2012 - Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo; Drug: St. Johns Wort
Sponsors: Lancaster General Hospital; Lancaster General Hospital; H. G. Barsumian Memorial Fund; Louise von Hess Medical Research Institute
Recruiting - verified January 2012 - Conditions: Acute Coronary Syndrome; Angioplasty, Transluminal, Percutaneous Coronary; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Blood Platelets
Interventions: Drug: rosuvastatin; Drug: placebo
Sponsors: University of Kentucky; University of Kentucky
Recruiting - verified March 2012 - Condition: Coronary Graft Patency
Interventions: Drug: clopidogrel; Drug: sugar pill
Sponsors: Brooke Army Medical Center; Ahmad Slim; Bristol-Myers Squibb
Recruiting - verified February 2012 - Conditions: Atherosclerosis; Percutaneous Coronary Intervention; Acute Coronary Syndrome
Interventions: Drug: cangrelor P2Y12 (platelet) inhibitor; Drug: Clopidogrel
Sponsors: The Medicines Company; The Medicines Company
Recruiting - verified September 2011 - Condition: Saphenous Vein Graft Atherosclerosis
Interventions: Device: Bare Metal Stent; Device: Drug-Eluting Stent; Drug: Blinded clopidogrel; Drug: Placebo; Drug: Thienopyridine (open-label)
Sponsors: Department of Veterans Affairs; Department of Veterans Affairs
Recruiting - verified March 2012 - Condition: Coronary Artery Disease
Intervention:
Sponsors: The Methodist Hospital System; The Methodist Hospital System
Recruiting - verified June 2011 - Condition: Ischemic Attack, Transient
Interventions: Drug: Clopidogrel; Drug: placebo
Sponsors: University of California, San Francisco; University of California, San Francisco; Neurological Emergencies Treatment Trials Network (NETT); Medical University of South Carolina; The EMMES Corporation
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Intervention: Drug: Atorvastatin
Sponsors: Indiana University; Indiana University School of Medicine; National Center for Research Resources (NCRR)
Recruiting - verified November 2010 - Conditions: Stroke; Transient Ischemic Attack
Interventions: Drug: Antithrombotic treatment; Device: percutaneous device closure of PFO
Sponsors: University Hospital Inselspital, Berne; University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland; University of Lausanne Hospitals; University Hospital, Geneva; University Hospital, Zürich; Triemli Hospital; Cantonal Hospital of Aarau, Switzerland; Alfried-Krupp Krankenhaus of Essen, Germany; University Hospital, Essen; Klinikum Worms gGmbH, Germany; Tufts Medical Center; Baystate Medical Center; East Medical Center Tyler, Texas; Universitaire Ziekenhuizen Leuven
Recruiting - verified January 2012 - Condition: Coronary Artery Disease
Interventions: Drug: Clopidogrel; Drug: Placebo
Sponsors: Deutsches Herzzentrum Muenchen; Deutsches Herzzentrum Muenchen
Recruiting - verified April 2012
 |
Clopidogrel Clinical Trials |
